<DOC>
	<DOCNO>NCT00486486</DOCNO>
	<brief_summary>The objective crossover , randomize , placebo control , double-masked study compare short-term ( 12 week ) mean 24-hour IOP control safety new fix combination ( bimatoprost/timolol , BTFC ) give PM placebo morning , versus BTFC give AM placebo even versus bimatoprost give even patient exfoliative glaucoma ( XFG ) .</brief_summary>
	<brief_title>24-hour Intraocular Pressure ( IOP ) Control With Bimatoprost/Timolol Fixed Combination</brief_title>
	<detailed_description>PRIMARY STUDY OBJECTIVES - To show mean 24-hour IOP control obtain BTFC ( morning evening ) statistically good bimatoprost monotherapy give even . - To demonstrate fix combination provide significantly good IOP control morning dose evening . - To test whether mean 24-hour IOP control obtain BTFC give evening may statistically better BTFC give morning . - To show whether less 24-hour fluctuation IOP evening dose BTFC . STUDY POPULATION Consecutive newly-diagnosed , suitably washed-out patient exfoliative glaucoma ( XFG ) exhibit mean untreated IOP great 25 mm Hg baseline ( 10:00 ) .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>The patient suffer XFG ( patient bilateral XFG , eyes treat , bad eye select statistical analysis ) Patient old 39 year younger 85 year Patient able willing participate study whole duration follow . Will sign consent form . At screen untreated IOP 10:00 ( ± 1 hr ) great 25 mm Hg low 40 mm Hg After bimatoprost runin therapy treat IOP 10:00 ( ± 1 hr ) great 19 mm Hg</criteria>
	<gender>All</gender>
	<minimum_age>39 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>24-hour IOP control</keyword>
</DOC>